AKBA
Akebia Therapeutics, Inc.
0.865$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -197.0% | – | – | – | – | – | – | – | – | |
| – | +95.9% | +208.3% | +108.4% | +292.4% | +1,496.3% | -13.1% | +13.0% | -0.7% | +11.0% | -10.4% | -96.6% | |
| – | -21.6% | +23.6% | +52.2% | +114.7% | -37.4% | +105.1% | -7.1% | -21.5% | -47.8% | -16.6% | +45.1% | |
| – | -21.6% | +30.1% | +100.3% | -66.5% | +270.4% | +948.5% | -76.8% | +26.1% | – | – | – | |
| – | -8.8% | +6,249.3% | -96.1% | +396.9% | -375.1% | – | – | – | – | – | – | |
| – | +80.8% | +543.0% | -39.1% | -1.0% | +314.4% | -95.2% | -81.4% | +93.2% | -100.0% | – | +781.8% | |
| – | -79.1% | – | -1,495.2% | – | +477.1% | -118.9% | – | -100.3% | – | – | +23,918.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -19.4% | +73.6% | -16.9% | -100.4% | – | -58.0% | -91.5% | -100.0% | – | – | |
| – | -103.0% | +185.7% | -75.0% | +280.0% | – | -68.1% | -265.2% | +0.0% | -3.0% | – | +20.7% | |
| – | -20.4% | -19.4% | +73.6% | -16.9% | -7.9% | +160.4% | -42.3% | -89.1% | -272.7% | – | +46.8% | |
| – | +47.0% | +709.3% | -185.2% | – | +19.7% | +90.4% | -197.5% | – | – | – | +1,382.5% | |
| – | – | – | -204.6% | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.